Author

Kit Gallagher

Moffitt Cancer CenterORCID 0000-0003-1401-115XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Organism:human· 1

Frequent Co-Authors

Maximilian A.R. StrobliD· 2 shared Agata XellaiD· 1 shared Alexander R.A. AndersoniD· 1 shared Chandler GatenbeeiD· 1 shared Dawn LemanneiD· 1 shared Erin M. GeorgeiD· 1 shared Lucia MazzacuratiiD· 1 shared Paulo C. Rodrı́gueziD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Maximilian A.R. StroblORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJul 10, 2025

Controlling treatment toxicity in ovarian cancer to prime the patient for tumor extinction therapy

Kit Gallagher, Rachel S Sousa, Chandler Gatenbee…·Maximilian A.R. Strobl

This paper develops computational frameworks to design personalized multi-strike therapies for ovarian cancer that reduce toxicity while enhancing tumor extinction.

DOI 10.1101/2025.07.10.664235

humanstatistical model

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 3, 2025

Predicting Treatment Outcomes from Adaptive Therapy -- A New Mathematical Biomarker

Kit Gallagher, Maximilian A.R. Strobl, Philip K. Maini, Alexander R.A. Anderson

This paper develops mathematical biomarkers to predict treatment outcomes for adaptive therapy in cancer, showing personalized strategies outperform standard-of-care protocols.

2 citations

statistical modeldrug response / drug discovery

𝕏 PostBluesky